Tainted Supplement Warnings Stress FDA’s Enforcement Limitations
This article was originally published in The Tan Sheet
Executive Summary
FDA issued public notifications against 20 products marketed as weight-loss supplements containing the withdrawn Rx ingredient sibutramine.
You may also be interested in...
GAO Adulteration Report Points To Disconnect Among FDA Offices
Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.
GAO Adulteration Report Points To Disconnect Among FDA Offices
Food and drug attorneys critique the Government Accountability Office’s report on FDA’s efforts to counter economically motivated adulteration, which calls for greater cross-agency collaboration.
Supplement Industry Must Step Up As Adulteration Threat Grows – FDA
The supplement industry has not done enough to aid FDA in pursuing firms adulterating products with drugs or getting the message out about adulteration, the agency says. Increased vigilance is needed especially as bad actors become more sophisticated and expand their adulteration activities.